Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 226 participants.

Also called NCT02408120

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose health services research
Phase
Phase 4
Enrolled
  • 226 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02408120
Other papers using this trial's data
  • Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study Diabetes care, 2022-10-01 DOI, PubMed 35675498, PMC9643128 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02408120. Randomized; no masking; primary purpose health services research. Start 2015-10 (registry gives no type); primary completion 2019-12-11 (actual). Results posted on 2021-01-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Insulin glargine
Intervention (Drug)
Insulin aspart
Intervention (Drug)
Supplemental insulin aspart
Lead sponsor
Emory University (class: other)

Record details

Record id
cardio:ct-nct02408120
Content hash
f47b9db3298d107b62c77c40ec6899db0203c2ddda8f56b2521465925054bc69